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The ubiquitin-proteasome system catalyzes the deg-
radation of intracellular proteins. Although ubiquiti-
nation of proteins determines their stabilities, there is
growing evidence that proteasome function is also
regulated. We report the functional characterization of
a conserved proteasomal regulatory complex. We
identified DmPI31 as a binding partner of the F box
protein Nutcracker, a component of an SCF ubiquitin
ligase (E3) required forcaspaseactivationduringsperm
differentiation inDrosophila. DmPI31 binds Nutcracker
via a conserved mechanism that is also used by
mammalian FBXO7 and PI31. Nutcracker promotes
DmPI31 stability, which is necessary for caspase
activation,proteasome function, andspermdifferentia-
tion. DmPI31 can activate 26S proteasomes in vitro,
and increasing DmPI31 levels suppresses defects
caused by diminished proteasome activity in vivo.
Furthermore, loss of DmPI31 function causes lethality,
cell-cycle abnormalities, and defects in protein degra-
dation, demonstrating that DmPI31 is physiologically
required for normal proteasome activity.
INTRODUCTION
The ubiquitin-proteasome system (UPS) is the major system for
selective degradation of proteins in eukaryotic cells, and is impli-
cated in the regulation of most cellular processes, including cell-
cycle control, transcription, signal transduction, inflammation,
and cell viability (Finley, 2009; Glickman and Ciechanover,
2002). Protein substrates are targeted for degradation by a set
of enzymes that attach multiple molecules of the small protein
ubiquitin (Ub). These include the Ub-activating enzymes (E1s),
Ub-conjugating enzymes (E2s), and a variety of Ub-protein
ligases (E3s), which are responsible for substrate recognition
and specificity (Glickman and Ciechanover, 2002).
The 26S proteasome is a large protease complex composed
of two major components: the core or catalytic particle (CP or
20S), a cylindrical particle within which polypeptides are hydro-
lyzed to small peptides. The 20S proteasome is associatedwith one or two regulatory particles (RP or 19S) that bind the
ubiquitinated substrate, unfold it, and translocate the extended
polypeptide through the narrow entry channel of the CP (Coux
et al., 1996; Demartino and Gillette, 2007; Finley, 2009). Recent
studies have identified many loosely associated proteins of this
structure, which may function as regulators or cofactors, but
the precise activities of most of these proteins remains elusive
(Besche et al., 2009; Finley, 2009).
An added level of proteasomal regulation is the replacement of
the 19S RPwith alternative activator complexes, such as REGab
(PA28ab or 11S), REGd (PA28d), and Blm10 (PA200) (Ma et al.,
1992; Masson et al., 2001; Tanahashi et al., 1997; Ustrell et al.,
2002). These complexes can bind to either or both end of the
20S particle, and enhance the entry and degradation of small
peptide substrates (Stadtmueller and Hill, 2011; Whitby et al.,
2000). Given the variety and complexity of these regulatory
components, and the growing number of proteasomeassociated
proteins being identified, it is clear that proteasomes are much
more complicated, more diverse and highly regulated structures
than previously thought (Demartino and Gillette, 2007).
Here, we describe the identification and functional character-
ization of a proteasome regulatory complex that controls cas-
pase activation and spermatogenesis in Drosophila. Caspases
are the key executioners of apoptosis, but during terminal sperm
differentiation they are utilized for an apoptosis-like process that
eliminates excess organelles and cytoplasm (Arama et al., 2003).
Nonlethal caspase activity is also used in other examples of
cellular remodeling, such as neuronal pruning (Kuo et al., 2006;
Nikolaev et al., 2009; Williams et al., 2006). Neuronal remodeling
is important for normal development, but has also been impli-
cated in neurodegenerative diseases (Nikolaev et al., 2009;
Raff et al., 2002; Tai and Schuman, 2008). Therefore, insights
into cellular remodeling and the proteases that mediate it will
likely contribute to a better understanding of these diseases.
From a screen for genes that control caspase activation during
terminal sperm differentiation, we isolated the F box protein
Nutcracker, the substrate-binding unit of an SCF Ub-ligase
complex (Bader et al., 2010). Mutations in nutcracker abrogate
caspase activity and prevent the progression of cellular remodel-
ing, resulting in sterility. We describe the identification and char-
acterization of a Nutcracker-binding partner, DmPI31, discov-
ered in a proteomic screen for Nutcracker interactors. We
show that DmPI31 stability is promoted by Nutcracker, andCell 145, 371–382, April 29, 2011 ª2011 Elsevier Inc. 371
Figure 1. Proteomic Screen for Nutcracker Interacting Proteins
(A) Scheme for testis-specific interactors of Nutcracker; PrA-nutcracker (PrA-ntc) was specifically expressed in testeswith the Don-Juan (DJ) promoter. Testes were
dissected, lysed,and incubatedwith IgGbeads. Interactingcomplexeswereelutedoff thebeads, and identifiedbyeithermass-spectrometryorwesternblot analysis.
(B) SDS-PAGE Coomassie blots of Nutcracker interactors from cell lysate. PrA-ntc or PrA-ntcDF were expressed in S2 cells and used to make lysates for
coimmunoprecipitation (co-IP) assays. Non-PrA-expressing cells were used as a negative control. An arrow marks the DmPI31 band. See also Figure S1.
(C) PrA-ntc is associated with proteasomes in vivo. PrA-ntc was expressed in testes and used for co-IP assays. Probing with an antibody against the proteasome
subunit alpha7 shows that PrA-ntc forms a complex with proteasome proteins in vivo.
(D) The Nutcracker-DmPI31 interaction is not dependent on the F box domain. PrA-ntc or PrA-ntcDF were expressed in testes and used to make lysates for co-IP
assays. Non-PrA-expressing wild-type testes (yw) were used as a negative control. DmPI31 binding was detected by Western-blot analysis using a DmPI31
antibody.
(E) Nutcracker-DmPI31 binding ismediated by a specialized domain. A conserved valine in Nutcracker thatmediates the interaction between the human PI31 and
the F box protein FBXO7wasmutated to investigate its importance for DmPI31-Nutcracker binding. PrA-ntc or PrA-ntcV-Ewere expressed in S2 cells and lysates
were used for co-IP. Non-PrA-expressing cells were used as a negative control.that they functionally cooperate to activate caspases and drive
sperm differentiation. Furthermore, we find that DmPI31, which
was originally described as a proteasome inhibitor in mammalian
systems, can activate purified 26S proteasomes in vitro (Chu-
Ping et al., 1992; McCutchen-Maloney et al., 2000; Zaiss et al.,
1999, 2002). Elevated levels of DmP31 can suppress phenotypes
caused by reduced proteasome activity in vivo. Finally, loss-of-
function mutations in DmPI31 are lethal, demonstrating that
this protein has an essential physiological function. DmPI31
mutants accumulate polyubiquitinated proteins and display
cell-cycle abnormalities, suggesting that DmPI31 is physiologi-
cally required for normal proteasome activity in vivo. These find-
ings reveal a conserved mode of proteasome regulation.
RESULTS
Proteomic Screen to Identify Nutcracker Interacting
Proteins
Nutcracker is a Drosophila F box protein previously identified in
a screen for mutants that fail to activate caspases during sper-372 Cell 145, 371–382, April 29, 2011 ª2011 Elsevier Inc.matid differentiation (Bader et al., 2010). To further understand
its role in caspase activation and spermatogenesis, we sought
to identify interacting partners by coimmunoprecipitation
(co-IP) of Nutcracker followed by identification of associated
proteins using mass-spectrometry (Figure 1A).
A protein-A (PrA) tagged version of full-length Nutcracker
(PrA-ntc) was expressed in both Drosophila testes and S2 cells.
After co-IP, the interacting proteins were identified using MS/MS
mass-spectrometry (Figure 1B and Figure S1A available online).
This revealed a group of proteins belonging to the UPS, primarily
proteasome subunits (alpha1 and alpha7). Co-IP experiments
confirmed that Nutcracker can associate with proteasomes
in vivo (Figure 1C). In addition, we identified a putative protea-
some inhibitor, DmPI31 (CG8979), as a binding partner of
PrA-ntc in both S2 cells and testes (Figures 1B and 1D and Fig-
ure S1A). The interaction between Nutcracker and DmPI31
appears to be direct since both proteins can bind each other in
a yeast two-hybrid assay (Giot et al., 2003). Next, we generated
an antibody against recombinant DmPI31 and confirmed that
this interaction occurs in vivo (Figure 1D). We chose to focus
on DmPI31 because of its potential role in regulating the
proteasome.
DmPI31-Nutcracker Interaction Depends
on the Conserved FP Domain
We previously showed that the F box domain of Nutcracker is
important for binding Cullin1 and SkpA (Bader et al., 2010). To
determine if the F box domain is also required for Nutcracker-
DmPI31 binding, we performed co-IP experiments using testes
expressing either the original PrA-ntc, or a truncated version
that lacks the F box domain (PrA-ntcDF). Co-IP of both PrA-ntc
and PrA-ntcDF resulted in enrichment of DmPI31 (Figure 1D).
This suggests that the interaction between Nutcracker and
DmPI31 is independent of the F box domain.
To further investigate the nature of Nutcracker-DmPI31 inter-
action, we looked at a related, structurally defined association
between the mammalian F box protein FBXO7 and PI31 (Kirk
et al., 2008). Nutcracker has some homology with FBXO7 and
they share a critical conserved valine (Figure S1B) that is
required for FBXO7-PI31 binding. We mutated this valine
in Nutcracker (V > E) to examine its significance in the
Nutcracker-DmPI31 interaction. As shown in Figure 1E, signifi-
cantly less endogenous DmPI31 was bound to the mutant
Nutcracker protein than the wild-type form. These results show
that the conserved FP domain is essential for interaction with
DmPI31.
DmPI31 Is Highly Expressed in the Testes and Is
Localized to Individualization Complexes
DmPI31 is the Drosophila homolog of mammalian PI31 proteins,
which have been found to inhibit the activity of purified 20S pro-
teasomes (Chu-Ping et al., 1992; McCutchen-Maloney et al.,
2000; Zaiss et al., 1999). The Drosophila homolog shares over
45% homology with these proteins (Figure 2A). DmPI31 mRNA
is expressed throughout the Drosophila lifecycle, but drops
substantially in the adult female (Arbeitman et al., 2002; Gauhar
et al., 2008). Semiquantitative RT-PCR experiments demon-
strated that mRNA levels in adult females are equivalent to those
of son-of-oskar males, which lack germ cells and functioning
testes. This suggests that the majority of adult mRNA resides
in testes (Figure 2B).
In order to determine the expression and intracellular localiza-
tion of DmPI31, testeswere stainedwith theDmPI31 antibody. At
the onset of terminal sperm differentiation, in a process called
‘‘individualization,’’ actin-rich cones form around the nuclei to
create the Individualization Complex (IC) (Figures 2C and 2D;
Fuller, 1993). As the ICmoves,most of the cytoplasm and excess
organelles are expelled in an inflated structure called the cystic
bulge (CB). Nutcracker protein is highly localized around the
IC’s actin cones in the CB (Figure 2E and Bader et al., 2010).
DmPI31 is distributed in a very similar pattern (Figures 2E and
2F), and both proteins can colocalize upon expression in cultured
cells (Figure S2). This suggests that DmPI31 and Nutcracker
localize to the same cellular compartment during individualiza-
tion, consistent with their physical interaction in vivo.
We also generated a mCherry-DmPI31 fusion protein driven
by the dmPI31 endogenous promoter. This reporter displayed
a similar subcellular distribution as the antibody staining, indi-cating that the fusion protein is properly localized (Figure 2G).
Furthermore, mCherrry-DmPI31 was able to rescue the lethality
of dmPI31 mutants (see below). Therefore, this fusion protein
can substitute for endogenous DmPI31 protein and appears to
be a faithful reporter for DmPI31 localization and behavior.
Nutcracker Controls DmPI31 Protein Levels
Since the Nutcracker-DmPI31 interaction is independent of the F
box domain, we asked whether DmPI31 might be a substrate of
the Nutcracker-containing SCF ubiquitin ligase. If DmPI31 is
a substrate for Nutcracker-mediated degradation, we would
haveexpectedDmPI31 toaccumulate in themutants. In contrast,
DmPI31 levels were greatly reduced in testes of both Nutcracker
null (nutcracker07259) or truncated F box (nutcrackerms771)
mutants (Figure 3A) (Bader et al., 2010). Instead, smaller molec-
ular weight products were detected. The full-length DmPI31
band was fully restored in nutcrackerms771/ flies that express
wild-type Nutcracker (nutcracker ‘‘rescue’’ transgenes: hsp83-
nutcracker). This indicates that DmPI31 is cleaved in a nutcracker
mutant background, suggesting that Nutcracker positively regu-
lates DmPI31 protein stability. Also, because an F box-truncated
formofNutcracker (nutcrackerms771/) still destabilizesDmPI31,
it appears that the F box domain is important for stabilizing
DmPI31. Finally, we investigated whether the cleavage of
DmPI31 in a nutcracker mutant background depends on cas-
pases or proteasome activity and found no evidence for an
involvement of these proteases (Figure S3A).
The amino-terminal region of PI31 is structured and contains
the FP domain, while the carboxy-terminal end, which contains
proline-rich sequences, is unstructured (Kirk et al., 2008;
McCutchen-Maloney et al., 2000) (Figure 2A). We therefore
investigated whether the cleaved form of DmPI31 seen in lysates
of nutcracker mutants is the result of random proteolysis, or
cleavage of a specific portion of the protein. For this purpose,
we expressed mCherry-DmPI31 in a nutcracker771/ mutant
background and probed with an anti-mCherry antibody. If
cleavage of DmPI31 were near the C terminus, the resulting
band would decrease by approximately 10 kDa. On the other
hand, if the cleavage were near the N terminus, we would expect
the molecular weight to decrease by 20 kDa (see diagram in Fig-
ure 3B). The size of mCherry-DmPI31 in a nutcracker mutant
background decreased by 10 kDa. Since mCherry-DmPI31 is
biologically active, we assume that the cleavage site is not
affected by the presence of the mCherry tag and conclude that
the C terminus of DmPI31 is truncated in a nutcracker mutant
background. The C terminus of mammalian PI31 is required for
proteasome interaction, so loss of nutcracker function is pre-
dicted to inactivate DmPI31 (McCutchen-Maloney et al., 2000).
Next, we investigated if the interaction between DmPI31 and
Nutcracker is lost upon truncation of the DmPI31 C-terminal
domain. We repeated the co-IP experiment, but this time we
expressed PrA-ntc in the testes of the nutcrackerms771/mutant
flies (Figure 3C). PrA-ntc was able to IP both the full-length and
cleaved forms of DmPI31, indicating that the cleaved form is
folded and capable of interacting with Nutcracker. This suggests
that the phenotypes observed in nutcracker mutants result from
the cleavage of DmPI31, and not simply from the inability of both
proteins to interact.Cell 145, 371–382, April 29, 2011 ª2011 Elsevier Inc. 373
Figure 2. DmPI31 Is Localized to Individualization Complexes
(A) Multiple alignments of DmPI31 and three mammalian homologs (bovine, mouse, and human). DmPI31 shares overall 45% homology with the mammalian
proteins, corresponding to 29% identity and 16% similarity. In particular, the DX7H and YXLXY motifs, which are important for the PI31 structure, are highly
conserved (labeled in yellow and green, respectively). Highlighted in blue are amino acids that mediate PI31-FBXO7 binding (Kirk et al., 2008). In pink is the
Hydrophobic-Tyrosine-X (HbYX) motif. All accession numbers are listed in the M&M.
(B) DmPI31 mRNA is abundant in adult testes. Semiquantitative RT-PCR of dmPI31 mRNA transcripts taken from whole-body adult females, wild-type males or
son-of-oskarmales, which lack germ cells. These are also compared tomRNA transcripts fromwild-type testes or son-of-oskar testes. Beta-tubulin primers were
used as control for total mRNA concentrations. Shown is cycle 25, five cycles before saturation.
(C) Schematic diagram of spermatid individualization. An actin-based individualization complex (IC, red) forms around the elongated nuclei of 64 spermatids
(gray) that are connected by cytoplasmic bridges. As the IC moves, cytoplasm (green) and organelles are collected in the cystic bulge (CB) and eventually
discarded in the waste bag (WB), generating individual sperm devoid of most cytoplasm and organelles.
(D) Caspase staining of individualizing cysts. Wild-type cysts were stained with DAPI (nuclei, blue), phalloidin (IC, red) and anti-active-caspase-3 (cytoplasm,
green).
(E–G) DmPI31 and Nutcracker localize to the same sub-cellular region during individualization. (E) Nutcracker staining during individualization as detectedwith an
antibody that specifically recognizes this protein (Bader et al., 2010). Nutcracker staining was seen at the base of the nuclei when the actin cones form around it
(inset), and in a circular pattern around the cones in the CB (asterisks). (F) DmPI31 antibody staining. Like Nutcracker, DmPI31 protein is detected at the base of
the elongated nuclei (inset), and colocalizes in a circular pattern with the actin cones (asterisks). Colocalization was also seen in cultured cells (Figure S2) (G)
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Nutcracker and DmPI31 Act Together to Activate
Caspases and Control Sperm Differentiation
We asked if the interaction between the two proteins is important
for their biological activity in vivo. For this purpose, we mutated
the FP domain of Nutcracker and tested whether a transgene
carrying this mutation can rescue nutcrackerms771/. Although
both constructs were expressed at similar levels (Figure S3B),
hsp83-nutcrackerV-E transgenenic flies were unable to rescue
the nutcrackerms771/ sterility phenotype (Table 1). When we
stained testes from these males with the caspase3 antibody,
we noticed that some staining was restored, demonstrating
that the mutated construct was partially functional (data not
shown). However, it appears that full Nutcracker activity requires
binding to DmPI31.
We then investigated if the inability of the mutated rescue con-
struct to restore fertility is caused by persistent DmPI31 cleavage.
We found that hsp83-nutcrackerV-E;nutcrackerms771/ still
displayed DmPI31 cleavage, albeit less than in the original
nutcrackerms771/ homozygotemutant line (Figure 3D). This indi-
cates that the interaction between Nutcracker and DmPI31 is
important for Nutcracker’s role in stabilizing DmPI31, and that
this stabilization is crucial for proper sperm differentiation.
If Nutcracker functions through DmPI31 stabilization to
promote caspase activation and sperm differentiation, it may be
possible toat leastpartially compensate for the lossofNutcracker
function by expressing DmPI31. We overexpressed DmPI31 in
a nutcrackerms771/ mutant background and observed partial
restoration of caspase staining (Figure 3E). This suggests that
Nutcracker activates caspases, at least in part, by stabilizing
DmPI31. According to this interpretation, Nutcracker is dispens-
able for caspase activation if sufficient amounts of full-length
DmPI31 are expressed in spermatids. Taken together, our results
demonstrate that Nutcracker and DmPI31 need to physically
interact for their full biological activities.
DmPI31 Can Stimulate 26S Proteasomes In Vitro
PI31 proteins were identified as inhibitors of the catalytic particle
of the proteasome based on the ability of recombinant bovine
PI31 to inhibit purified 20S proteasomes (Chu-Ping et al., 1992;
McCutchen-Maloney et al., 2000; Zaiss et al., 1999). Subsequent
studies also demonstrated PI31’s ability to compete with 19S
and 11S regulatory particles which resulted in a net inhibitory
effect (McCutchen-Maloney et al., 2000). In order to understand
themolecular role ofDrosophila PI31 in regulating spermatogen-
esis, we investigated its effect on the proteasome’s peptidase
activity. Recombinant DmPI31 was purified from E. coli and
added to purified mammalian 20S proteasomes. As expected,
DmPI31 inhibited 20S activity (Figure 4A). Surprisingly, when
purified DmPI31 was added to mammalian 26S proteasomes,
its peptidase activity was enhanced up to 3-fold (Figure 4A).
Thus, when the 20S CP is associated with the 19S RP (and
possibly various other interacting proteins), DmPI31 enhances
proteasome function, in contrast to the inhibitory effect on puri-
fied 20S CP.mCherry-DmPI31 fusion protein localization during individualization. This fusion
localized in a pattern virtually identical to DmPI31 antibody staining. mCherry-Dm
elongated nuclei (inset), colocalizing with the actin cones as they move down theThe capacity of 26S and 20S proteasomes to degrade small
peptides is determined by whether the gate for its substrate-
entry channel is in its open conformation, and in the 26S particle,
this entry is regulated by the ATPases in the 19S (Smith et al.,
2005). Such an effect on gating could be mediated by DmPI31’s
C terminus Hydrophobic-Tyrosin-X (HbYX) motif that in 19S
ATPases allows interaction with the proteasome and induces
gate opening (Rabl et al., 2008; Smith et al., 2007). Consistently,
we found that mutant DmPI31 protein lacking the HbYX motif
could still activate the 26S, but with a reduced efficiency (Fig-
ure 4B). This suggests that while the HbYX domain is important
for proteasome activation, it may not be the only domain that
mediates activation and binding. The difference in DmPI31 effect
on the 20S versus 26S suggests that other domains in DmPI31
may bind to the 19S regulatory subunit as well. Collectively,
the in vitro data indicate that DmPI31, despite its original desig-
nation as a proteasome inhibitor, can function as an activator of
the 26S proteasome, which is the dominant form in vivo (Besche
et al., 2009).
Ectopic Expression of DmPI31 Increases Proteasome
Activity In Vivo
We conducted a series of genetic studies to determine whether
DmPI31 can affect proteasome activity in vivo. First, we analyzed
whether expression of DmPI31 had an effect on phenotypes
caused by impaired proteasome function. Targeted expression
of the dominant temperature sensitive proteasome alleles
UAS-DTS5 and UAS-DTS7 with GMR-Gal4 at 29C causes
a small, rough eye phenotype (Belote and Fortier, 2002) (Figures
5B and 5C). Coexpression of DmPI31 with these constructs sup-
pressed this phenotype (Figure 5D). This appears to be a direct
effect on boosting proteasome activity because expression of
DmPI31 did not increase the expression of proteasome subunits
(Figure 5E). Conversely, reducing DmPI31 function significantly
enhanced the phenotype of the DTS alleles (Figures 5F–5J).
Whereas expression of either DTS allele at 25C caused no
detectable eye phenotype, downregulation of DmPI31 via RNAi
caused a strong eye phenotype in the background of both DTS
alleles (Figures 5F–5J). At 29C, this allelic combination results
in organismal lethality (Figures 5K–5N). These results show that
DmPI31 can modify proteasome activity in vivo and suggests
that DmPI31 functions as a proteasome activator.
DmPI31 Is Physiologically Required for Proteasome
Function
To determine the physiological function of DmPI31, we gener-
ated loss-of-function mutations in this gene by homologous
recombination (Gong and Golic, 2003). dmPI31 mutants are
recessively lethal and die at the late third instar larval/early pupal
transition, a developmental stage wheremany cell cycle mutants
are lethal (Gatti and Baker, 1989; Orr-Weaver, 1994). Mutant
larvae also developed melanotic tumors, were slower to develop
and smaller. All these phenotypes were rescued by transgenic
expression of dmPI31 (using UASt-HA-PI31 transgenic fliesprotein is expressed under the control of dmPI31 endogenous promoter and
PI31 is seen in the combined cytoplasm of each cyst and at the base of fully
cyst (asterisks).
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Figure 3. Nutcracker Controls Caspase Activation and Sperm Individualization by Promoting DmPI31 Stability
(A) Mutations in nutcracker affect DmPI31 stability. Testes lysates of the indicated genotypes were used to detect steady-state DmPI31 protein levels. The
cleaved form of DmPI31 found in nutcrackermutants is indicated by an arrow. The lowest molecular weight band is unspecific and serves as loading control. yw
(wild-type), ms771+/ (nutcrackerms771 heterozygote), ms771/ (nutcrackerms771 homozygote), ms771(/) Rescue, (nutcrackerms771;hsp83-nutcracker),
ms07259 (nutcracker07259 homozygote).
(B) Mutations in nutcracker result in the C-terminal cleavage of DmPI31. Total lysates from either wild-type or nutcrackerms771/ homozygote flies expressing
mCherry-DmPI31 were used to detect the size of the fusion protein after cleavage. The diagram explains the expectedmolecular weights, which differ depending
on whether the cleavage is N or C terminal. The observed cleavage fragment was50 kDa, and clearly not37 kDa. This indicates that the C-terminal domain of
DmPI31 is truncated in nutcracker mutants.
(C) The cleaved form of DmPI31 can physically associate with Nutcracker. PrA-ntc was expressed in testes of either nutcrackerms771+/ or nutcrackerms771/
background and used to make lysates for co-IP. The cleaved form of DmPI31 found in nutcracker homozygote mutants is indicated by an arrow. Non-PrA-
expressing (yw) testes were used as a negative control.
(D) DmPI31 stability depends on Nutcracker binding. Testes lysates from nutcrackerms771/ homozygote mutants expressing the indicated rescue constructs
were used to detect steady-state DmPI31 protein levels. hsp83-nutcracker and hsp83-nutcrackerV-E rescue constructs are labeled wt and V-E, respectively. The
cleaved form of DmPI31 found in nutcracker mutants is indicated by an arrow. This cleavage is not dependent on caspase or proteasome protease activity
(Figure S3A). The lowest molecular weight band is unspecific and serves as loading control.
(E) Overexpression of DmPI31 is sufficient for caspase activation in the absence of nutcracker function. Active caspase-3 staining is shown in green and actin
filaments (phalloidin staining) in red. Overexpression of DmPI31 in wild-type testes has no detectable effect on caspase-3 staining (left panel). Whereas
nutcrackerms771/ mutant testes lack caspase-3 staining (middle panel), expression of DmPI31 restores readily detectable caspase activity (right panel).under the control of the tubulin-Gal4, tubulin Gal80ts promoters
at 23C), demonstrating that the mutant phenotypes are indeed
caused by loss of dmPI31 function. On the other hand, high-level
overexpression of DmPI31 caused lethality (Table S1). This indi-
cates that cells are highly sensitive to the amounts of PI31, since
both elimination of the gene and overexpression are detrimental
and cause lethality. We also generated transgenic fly lines to376 Cell 145, 371–382, April 29, 2011 ª2011 Elsevier Inc.ectopically express various DmPI31 mutants for structure/func-
tion studies (Table S1). Consistent with our previous results,
truncation of the C-terminal region of DmPI31 abrogated the
ability of DmPI31 to stimulate proteasome activity.
Among the many cellular processes regulated by the UPS is
cell cycle progression. We therefore examined whether
dmPI31 mutants have cell cycle defects, focusing on the male
Table 1. Summary of nutcracker Mutant Rescue Experiments
Genotype Fertility
Caspase3
Staining
dmPI31
Cleavage Morphology
Wild-type (yw) 100% yes no normal
ms771(/) 0% no yes no IC formed, failure
to individualize
ms771(/) +
nutcracker-WT
100% yes no normal
ms771(/) +
nutcracker-V-E
0% yes partial incomplete
individualization
ms771(/) +
PI31
0% yes no IC formed, failure
to individualize
nutcrackerms771/ (ms771/) phenotypes rescued by ectopic expres-
sion of either wild-type nutcracker (nutcracker-WT), a nutcracker
construct containing a mutation that prevents binding to DmPI31
(nutcrackerV-E), or a DmPI31 construct (PI31). At least four transgenic
insertions were tested for each construct. A control for equal expression
is demonstrated in Figure S3B.
Figure 4. DmPI31 Can Stimulate Proteasome Activity In Vitro
(A and B) In vitro proteasome activity assays using Suc-LLVY-AMC substrate.
Rates are plotted relative to that of the control sample lacking DmPI31. Each
experiment was repeated several times with similar results. Error bars repre-
sent the standard deviation from three independent readings. (A) DmPI31 is an
inhibitor of 20S but an activator of the 26S proteasomes. Increasing concen-
trations of purified DmPI31 were used and the effect on the activity of purified
bovine 20S or 26S proteasomes was monitored by rate of fluorogenic
substrate hydrolysis. 0.15mg 20S or 0.05mg 26S were used per reaction (rxn).
(B) DmPI31 lacking the HbYX motif displays reduced ability to activate
mammalian 26S proteasomes. These experiments were preformed as in (A)
with 26S proteasomes. The K(apparent) was calculated by using the
concentration of DmPI31 or DmPI31-HbYX at saturation.germ line. By expressing DmPI31 transgenically in somatic cells
we were able to rescue organismal lethality and generate viable
‘‘mosaic’’ adults that lack dmPI31 function in germ cells because
germ cells use a different tubulin promoter than somatic cells
(Hoyle et al., 1995; Kemphues et al., 1980). When the testes of
these flies were dissected they appeared irregular and exhibited
a meiotic arrest phenotype, characterized by the abundance of
underdeveloped 16 cell stage cysts, which fail to undergo proper
meiosis (Lin et al., 1996). Antibody staining against DmPI31
confirmed the absence of protein in both the germline cells
(GSCs) and primary spermatocytes (Figure 6A).
Next, we stained testes with cell cycle markers. BrdU staining
at the tip of the testes closest to the hub was similar to the
wild-type, indicating that mitosis of germline cells proceeded
normally (Figure 6B). In contrast, when we stained with the phos-
pho-histone3 (PH3) antibody, which labels dividing nuclei, we
did not detect cysts in the 32 cell stage, suggesting that these
cells are not undergoing meiosis (Figure 6C). Furthermore, stain-
ing with the Vasa antibody, which is specific for germ cell
progenitors, showed that loss of DmPI31 function prevents
germ cell differentiation and leads to persistence of progenitor
identity (Jin et al., 2005) (Figure 6D). Moreover, we saw that cy-
clin B, a protein important for both mitotic and meiotic cell
cycles, that is degraded by the proteasome during the final
stages of meiosis, also persisted in these cells (Fuller, 1998) (Fig-
ure 6E and Figure S4). These results are consistent with the idea
that loss of DmPI31 impairs proteasome function and that
DmPI31 is a proteasome activator.
To further test whether dmPI31mutants have reduced protea-
some activity, we stained testes with the FK2 antibody, which
detects Ub-conjugated proteins and can therefore be used to
visualize polyubiquitinated, nondegraded proteins that accumu-
late when 26S proteasome function is impaired (Fujimuro et al.,
1997; Haas et al., 2007). In wild-type cells, FK2 staining was
diffuse in the cytoplasm and strong in the nucleus of meiotic cells
(Figure 6F). In contrast, in dmPI31mutant cells, punctate staining
was seen in most cells, and in some cases in one or two nuclei of
each cyst. This pattern of staining suggests that proteasomeactivity is defective, and that Ub-conjugates accumulate as intra-
cellular aggregates.Taken together, our results show thatDmPI31
is required for proper protein degradation and cell cycle progres-
sion, supporting a role of this protein as a proteasome activator.
DISCUSSION
A Conserved Proteasome Regulatory Complex
Is Required for Cellular Remodeling
We identified and characterized a proteasome regulatory
complex that combines two distinct components of the UPS,
an F box protein, which usually catalyzes ubiquitin-conjugation
to a set of substrates, and a proteasome regulator, which
promotes substrate hydrolysis by the proteasome. Although
several studies have reported the physical associationCell 145, 371–382, April 29, 2011 ª2011 Elsevier Inc. 377
Figure 5. DmPI31 Stimulates Proteasome Function In Vivo
Inhibition of proteasome activity in the developing retina causes phenotypes that are sensitive to the amounts of DmPI31 protein.
(A–E) Effects of expressing DmPI31 at 29C. (A) GMR-Gal4 expression in a wild-type background causes no detectable phenotype. (B) Inhibition of proteasome
function upon expression of the dominant-negative temperature-sensitive mutants UAS-DTS5 and UAS-DTS7 in the developing retina at 29C causes a small
rough eye phenotype. (C) This phenotype is not affected by coexpressingGFP, but (D) is suppressed by coexpressing full-length DmPI31, indicating that elevated
levels of DmPI31 can boost proteasome activity. (E) Western blot analysis of total eye lysates. The suppression of the rough eye phenotype is not caused by
upregulation of the proteasome subunits, as verified by probing alpha7 subunit levels.
(F–N) Depletion of DmPI31 enhances the eye phenotypes caused by reduced proteasome activity. Compared to flies expressing either dmPI31RNAi (F) or the DTS
proteasome mutants (G) at 25C, combined expression of both dmPI31RNAi and DTS proteasome mutant transgenes causes severe defects in eye development
(H–I). (J) Western blot demonstrating that the dmPI31RNAi construct results in DmPI31 knockdown. (K–N) Expressing either DTS5 or DTS7 together with
dmPI31RNAi at 29C, but not each alone, results in lethality. Structure-function studies of dmPI31 are summarized in Table S1.between certain Ub-ligases and the 26S proteasome, we now
demonstrate a clear functional significance of this interaction
in vivo (Demartino and Gillette, 2007; Finley, 2009). In particular,
we show that the F box protein Nutcracker and the proteasome
regulator DmPI31 function together as a complex to stimulate
proteasome activity during normal development. This elevated
proteasome activity is required for nonapoptotic caspase activa-
tion and sperm differentiation in Drosophila. The interaction of
DmPI31 and Nutcracker is mediated through their FP domain,378 Cell 145, 371–382, April 29, 2011 ª2011 Elsevier Inc.a conserved domain found in mammalian homologs (Kirk et al.,
2008). Therefore, it is possible that a similar mode of proteaso-
mal regulation operates in mammals.
Nutcracker Controls Caspase Activation and Sperm
Individualization by Promoting DmPI31 Stability
We initially considered that DmPI31 is a substrate of the
Nutcracker-containing SCF E3-ligase complex. However,
DmPI31 protein does not accumulate in nutcracker mutants, as
Figure 6. DmPI31 Has an Essential Physiological Function and Is
Required for Normal Proteasome Activity In Vivo
(A–F) dmPI31 mutants are lethal, but transgenic expression of DmPI31 in the
soma rescues this lethality and permits the recovery of adult flies that lack
DmPI31 in germ cells. These flies display defects in the cell-cycle and protein
degradation. The left panel depicts wild-type testes, while the right depicts
dmPI31 mutants that have been rescued to adulthood.
(A and A0) Distribution of DmPI31 protein in the testis. Testes were stained with
and antibody staining toward DmPI31 (green). The wild-type testis displays
staining in germline stem cells (GSCs) and primary spermatocytes. This
staining is lost in dmPI31 mutant testes. The inset depicts a larger magnifi-
cation of the apical tip, where these cells reside.
(B and B0) BrdU incorporation assay to detect dividing GSCs. Anti-BrdU
staining (green) labeling S-phase cells is detected at the apical tip of the wild-
type testis. A similar labeling is detected in the dmPI31mutant testis, indicating
that mitotic divisions are not disrupted. Nuclei are stained with DAPI (blue).
(C and C0) Phospho-histone 3 (PH3) antibody staining (green), which marks
meiotic divisions. The PH3 antibody stains dividing nuclei, and therefore
detects cells that are undergoing either mitosis or meiosis. Compared to wild-
type testis, which display staining in the nuclei of 32 cell cysts, no staining is
detected in cysts of dmPI31mutant testis, suggesting that meiosis is stunted.
An arrow points to a 32 cell cyst (enlarged in inset) where PH3 staining is
detected in wild-type.
(D and D0) Anti-Vasa antibody staining (green). This antibody is specific for
germ cell progenitors. During normal differentiation, Vasa staining is strongest
in GSCs and primary spermatocytes, and disappears when cells approach
meiosis. In contrast, dmPI31mutant testes contain cysts with persistent Vasa
staining, indicating that these cells maintain progenitor identity and fail to
differentiate.
(E and E0) Cyclin B staining. Cyclin B is normally detected in 16 cell stage cysts
and disappears just before meiosis completes. In dmPI31mutant cells, Cyclin
B persists in 16 cell stage cysts, indicating that the degradation of this protein
does not occur normally. See also Figure S4.
(F and F0) FK2 staining of ubiquitin-conjugated proteins. FK2 detects the
abundance of polyubiquitinated proteins and is thus a detector of proteasome
activity. In normal germline cells (a premeiotic cyst is circled), FK2 staining is
diffuse, and prominent staining is detected in differentiating nuclei (asterisks in
separate cyst). In contrast, most dmPI31 mutant cells display punctate
staining (arrows point to polyubiquitinated protein clusters), indicating accu-
mulation of nondegraded polyubiquitinated proteins.would be expected if it was a degradation substrate. Instead,
a nutcracker mutant that carries a stable but truncated F box
domain results in the cleavage and truncation of DmPI31. Hence,
the Nutcracker F box domain is required for the stability of full-
length DmPI31 and the proteasome-activating activity of this
protein (Figure 7). Furthermore, stabilization of DmPI31 by
Nutcracker is required for normal caspase activation, sperm
differentiation andmale fertility. First, loss of Nutcracker function
causes defects in caspase activation and male sterility (Bader
et al., 2010). Second, a nutcracker transgenewith reduced ability
to bind DmPI31 failed to protect DmPI31 from cleavage and did
not rescue nutcracker mutants. This suggests that binding of
Nutcracker to DmPI31 is critically important to positively regulate
DmPI31 by stabilizing this protein. Additionally, overexpression
of DmPI31 in a nutcracker mutant background was sufficient
for caspase activation (Figure 3E). This indicates that physical
interaction with DmPI31 is important for Nutcracker activity,
and that Nutcracker acts upstream of DmPI31 to control its
stability and function. Since general overexpression of DmPI31
is lethal, it appears that the levels of active (full-length) DmPI31
need to be carefully regulated.Cell 145, 371–382, April 29, 2011 ª2011 Elsevier Inc. 379
Figure 7. Model for Proteasome Regulation
by the Nutcracker-DmPI31 Complex
During their terminal differentiation, spermatids
undergo a severe reduction in cell volume. This
process, termed ‘‘individualization,’’ requires pro-
teasome activity (Zhong and Belote, 2007). Both
Nutcracker and DmPI31 are required for normal
proteasome activity in the testis (Bader et al.,
2010). The binding of Nutcracker stabilizes
DmPI31 by protecting the carboxy-terminal region
of DmPI31 from cleavage. The C-terminal domain
of DmPI31 is necessary for both binding to pro-
teasomes and to stimulate their activity (McCutchen-Maloney et al., 2000). This domain contains a HbYX motif that has been implicated in proteasome gate
opening (Smith et al., 2007). The formation and binding of the DmPI31-F box regulatory complex stimulates proteasome activity and promotes caspase activation
and spermatid differentiation. Since the function of Nutcracker is restricted to the testis, whereas DmPI31 has an essential function in somatic cells, it is likely that
other factors contribute to the regulation of DmPI31.DmPI31 Is a Proteasome Activator In Vivo
Contrary to the original identification of PI31 as a proteasome
inhibitor (PI), the physiological function of DmPI31 is to stimulate
proteasome activity in vivo. This stimulatory effect of PI31 on
proteasomes appears to be direct because DmPI31 can also
activate purified 26S proteasomes in vitro. The ability of
DmPI31 to enhance the degradation of standard tetrapeptide
substrates implies a role in promoting the opening of the
substrate-entry channel, a property exhibited by other protea-
some activating complexes (Rabl et al., 2008; Smith et al.,
2007). In support of this idea, DmPI31’s C-terminal HbYX motif,
which resembles the proteasome-interacting, gate-opening
domains on the proteasome regulatory ATPases, is also impor-
tant for DmPI31 activity (Rabl et al., 2008; Smith et al., 2007).
The physiological role of DmPI31 as an essential proteasome
activator is supported by the phenotypes of dmPI31 loss-of-
function mutants. Loss of dmPI31 function causes lethality, indi-
cating that this gene has a vital function. Furthermore, germ cells
lacking dmPI31 fail to undergo meiosis and maintain stem cell
identity. These phenotypes are consistent with defects in protein
degradation (Alessandrini et al., 1997; Fuller, 1998). Accordingly,
we observed that polyubiquitinated proteins accumulate in
dmPI31 mutant germ cells, proving strong evidence that
DmPI31 is required for normal proteasome activity in vivo.
Finally, a modest elevation of DmPI31 protein was able to
suppress phenotypes caused by reduced proteasome activity,
indicating that DmPI31 can boost proteasome activity in vivo.
Taken together, all these results argue that DmPI31 plays an
important physiological role as a proteasome activator.
Our findings may have important general implications for the
role of regulated proteolysis during cellular remodeling. Sperm
differentiation involves a major reduction in cell volume and
can be viewed, from a cell biological standpoint, as ‘‘pro-
grammed cell atrophy’’ (Arama et al., 2006; Bader et al., 2010;
Fabrizio et al., 1998; Noguchi and Miller, 2003; Zhong and Be-
lote, 2007). Similar dramatic morphological changes and organ-
elle breakdown also occur during the differentiation of other cell
types, for example, during neuronal pruning (Lecker et al., 2006;
Ventadour and Attaix, 2006). Consequently, it is possible that
proteasomes are positively regulated in these cases as well.
Furthermore, intracellular proteolysis mediated by both protea-
somes and caspases is associated with various pathologies380 Cell 145, 371–382, April 29, 2011 ª2011 Elsevier Inc.that involve cell and tissue wasting, including neural degenera-
tion and myopathies (Lecker et al., 2006; Raff et al., 2002; Sax-
ena and Caroni, 2007). Therefore, insights into the regulation of
protein degradation are highly relevant for a wide range of human
diseases. In the future, it will be in interesting to investigate if
a mechanism similar to what we describe here controls protea-
some activity in mammals, and whether it contributes to human
diseases that are associated with excessive protein turnover.
EXPERIMENTAL PROCEDURES
Fly Strains
yw flies were used as wild-type controls. The Zuker mutant Z3-4692 (ms771)
was obtained from C.S. Zuker; the son-of-oskar osk[301]/TM3 and osk[CE4]/
TM3 lines from R. Lehmann; w1118;70FLP,70ISceI and w1118;70FLP lines
from L.B. Vosshall; tubulin-Gal4 from HD. Ryoo; UAS-DTS5 and UAS-DTS7
were obtained from J. Belote; the deficiency lines Df(2R)BSC199 and Df(2R)
ED2247 and the PBac insertion PBac{WH}CG10855f07259 from the Blooming-
ton Stock Center, as were tubulin-Gal80ts and actin-Gal4. DmPI31 RNAi lines
were obtained from the Vienna Drosophila RNAi Center (VDRC).
Immunoprecipitations
Testes-IP was conducted as in (Bader et al., 2010). For S2 IP, cells were co-
transfected with Actin-Gal4 and different UAS constructs (Fugene6, Roche)
and left for 36–48 hr. Cells were washed twice in ice-cold PBS, lysed in
200 ml ice-cold 1% NP-40 in PBS, left on ice for 15 min, then spun at
14,000 rpm for 15min at 4C. The IP was then conducted similarly to the testes
IP, except the washes were done with ice-cold PBS. Total protein (0.5–1 mg)
was used for IP-western, and 7–10 mg for mass-spectrometry identification.
Mass Spectrometry Analysis
After co-IP, proteins were resolved by SDS-PAGE (4%–12% gradient) and
stained with Coomassie blue (GelCode Blue; Pierce). Visible bands were
excised and subjected to trypsin digestion. The resulting peptides were ex-
tracted, and proteins were identified by mass spectrometry at the Rockefeller
University Proteomics Resource Center. Peptides sequences were analyzed
using the MASCOT search engine (http://www.matrixscience.com/).
Western Blot Analysis
Western blot analysis was conducted as in (Bader et al., 2010) with anti-
DmPI31[sera], 1:1000, anti-HA, 1:5000 (Roche), anti-alpha7, 1:200 (Biomol),
mCherry 1:1000 (Clontech), cyclin B 1:1000 (Santa Cruz).
Antibody Generation and Tissue Staining
Cleaved effector caspase antibody staining of testes was as in (Bader et al.,
2010). Anti-DmPI31 was created in guinea-pigs with full-length recombinant
DmPI31 (Cocalico Biologicals, Inc.), and staining was as described in (Hime
et al., 1996) with serum diluted 1:250. Staining of wholemount testes and BrdU
incorporation followed (Beall et al., 2002), except cyclin B staining was as in
(Baker and Fuller, 2007). The following antibodies and dilutions were used:
mouse anti-BrdU-FITC 1:100 (BD-PharMingen), rabbit anti-Vasa 1:100 (a gift
from R. Lehmann), mouse anti-cyclin B clone F2F4 1:10 (DSHB) and mouse
FK2 1:100 (Stressgen).
Proteasome Activity Assay
Tomeasure proteasome activity, the fluorogenic peptide substrate Suc-LLVY-
amc (Enzo Life Sciences, maintained in DMSO) was used at a final concentra-
tion of 100 mM in reaction buffer (50 mM Tris, 5% glycerol). Hydrolysis of suc-
LLVY-amc was monitored at lex 380 nm and lem 440 nm. All reactions were
conducted in a 96-well plate and read on a SpectraMaxM2micro-plate reader
(Molecular Devices). For experiments on 20S proteasomes, 0.05–0.15 mg of
purified Bovine 20S was used per 100 ml reaction, at 37C. For experiments
on 26S proteasomes, 0.05 mg of purified Bovine 26S was used per 100 ml reac-
tion, in the same buffer plus 10 mM mgCl and 100 mM ATP, at 37C.
K(apparent) was calculated with the standard ligand binding equation using
Sigmaplot (http://www.sigmaplot.com) with DmPI31 concentration at satura-
tion as maximal affinity.
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